At­tor­neys gen­er­al bring an­oth­er ‘col­lu­sion’ case against gener­ic mak­ers, nam­ing No­var­tis and Pfiz­er among over a dozen oth­ers

For the third time in the last four years, a coali­tion of at­tor­neys gen­er­al have filed an an­titrust law­suit against some of the world’s largest gener­ic drug­mak­ers, in­clud­ing Pfiz­er, My­lan and No­var­tis’ San­doz unit, al­leg­ing that for years the com­pa­nies fixed prices and ma­nip­u­lat­ed the mar­ket for over 80 drugs.

The suit, brought by 51 at­tor­neys gen­er­al — in­clud­ing those of DC and every state be­sides Cal­i­for­nia, Utah, South Dako­ta and Wyoming — is the lat­est bram­ble in a le­gal thick­et that has en­snared the gener­ics in­dus­try since 2016, when 20 state at­tor­neys gen­er­al ac­cused Te­va Phar­ma­ceu­ti­cals and My­lan for an an­tibi­ot­ic and a di­a­betes drug. “We be­lieve that this is just the tip of the ice­berg,” then-Con­necti­cut At­tor­ney Gen­er­al George Jepsen said at the time.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER